Merck & Co Inc (MRK) Stock Could Soon Reward Patient Investors
Merck & Co Inc (NYSE: MRK) is -8.09% lower on its value in year-to-date trading and has touched a low of $81.04 and a high of $134.63 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts […]
Quarterly Results Took Shares Of MetLife (MET), Cigna (CI) High, And Merck’s (MRK) Low
MetLife, Inc. (MET) was up +5.12% to $51.9. For the fourth fiscal quarter, the U.S. insurer posted a better-than-expected rise in adjusted earnings, with investment growth and underwriting in some of its U.S. companies. The quarter’s adjusted earnings per share are $2.03, compared to $1.53 and $1.98 a year ago. The income was 20.6 billion […]
